@Article{, title={Hepatitis A in Kerbala: Eight Year Epidemiological Study}, author={Lamya A A Darwish and Hassan Ali A Nasrallah and Ali Al Mousaw}, journal={Karbala Journal of Medicine مجلة كربلاء الطبية}, volume={11}, number={1}, pages={3873-3883}, year={2018}, abstract={background: Viral hepatitis is a contagious disease that continues to be a global burden. We have noticed from our clinical practice that the number of cases is growing especially in Kerbala Province.Aim: we conduct this epidemiological study in Kerbala Province to investigate the incidence rate of Hepatitis A infection and to have an insight to the causative factors in view to addressing them and tackle this big health problem. Method: Data from The Infectious Diseases Registration Office in Kerbala health directorate was revised to review all registered hepatitis cases between 2010 and 2017.Results: of 9352 hepatitis patients, (58.8%) males and (41.2%) females registered in Kerbala Health governorate in eight years (2010-2017). Hepatitis A formed the majority of cases (61.7%) followed by hepatitis B and C. Converting frequency to incidence rates showed that the annual rate of the four main types of hepatitis were 0.069, 0.028, 0.013, 0.001 per 100,000 population, respectively. The incidence of hepatitis A rates in 2010-2017 in Kerbala fluctuated, however the median endemic was rising. Within the four main geographical areas in Kerbala (City Centre, Hindia, Al Hussainia and Hurr) the incidence of hepatitis A per 100,000 population was markedly higher in the city Centre. Children and adolescents were the mostly affected age groups as they formed more than three quarters of the patients, but there was no significant gender difference. Seasonal variation was very clear as summer months were marked with significant increase in incidence rates.Conclusion: Being a holy city where millions of pilgrims visit Imam Hussein (PUH) shrine appeared to play an important role in disease transmission where propagations started after religious occasions. Decision makers need to address the serious health issue and implement a more proactive plan for the near future.

} }